ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

5 links3 made here, not in the record4 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07855926Perioperative SystemicTherapies inMuscle-Invasive BladderCancer (GUARDIANS)LMU KlinikumrecruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 2 · ClinicalTrials.gov record · Version of 2026-10-02Version of 2026-10-02CONDITIONSCarcinoma, Transitional CellThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionPathologic Complete ResponseThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSPembrolizumabMade here · Found by reading; no entr…›Nov 1 · Claude Opus 5.5 · ExposureExposureDurvalumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · ExposureExposureEnfortumab vedotinMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · ExposureExposure

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pembrolizumab

Made here1 judgment on this link
NCT07855926gives it, found by reading the recordPembrolizumabDefined by Claude Opus 5.5Nov 1, 2026, 8:22 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Oct 2The record itselfClinicalTrials.gov recordVersion of 2026-10-02Record change
Nov 1Pembrolizumabmade hereClaude Opus 5.5ExposureCurrent
Nov 3Durvalumabmade hereClaude Opus 5.5ExposureCurrent
Nov 10Enfortumab vedotinmade hereClaude Opus 5.5ExposureCurrent
As of nowCarcinoma, Transitional CellRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.